Hereditary Cancer Testing Market Size, Share & Trends Analysis Report By Product | Forecast to 2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Will The Hereditary Cancer Testing Market Valuation Change Between Now And 2029?
In recent times, the hereditary cancer testing market has witnessed robust growth. An increase from $4.32 billion in 2024 to $4.75 billion in 2025, with a compound annual growth rate (CAGR) of 10.0%, is projected. Factors contributing to this growth during the historic period include an increase in the prevalence of hereditary cancers, genetic counseling initiatives, government-funded cancer prevention programs, better insurance coverage, greater understanding of gene-environment interactions, and the emergence of patient advocacy and support groups.
In the coming years, predictions indicate a swift escalation in the hereditary cancer testing market size. The projection suggests a leap to $7.27 billion by 2029, increasing at a compound annual growth rate (CAGR) of 11.3%. This growth during the forecast period can be attributed to several factors such as the expansion of targeted therapies, advances in precision medicine, the increase in direct-to-consumer testing, global health initiatives, plus progress in bioinformatics. Expected trends for the period include improvements in genetic sequencing technologies, the proliferation of telemedicine and remote genetic counseling, precision medicine, personalized treatment, models for cancer risk assessment, and considerations of ethical and legal aspects.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8121&type=smp
What Underlying Factors Are Supporting The Hereditary Cancer Testing Market Growth?
The rise in incidences of inherited cancer is anticipated to fuel the growth of the market for hereditary cancer testing. Hereditary cancer syndromes are caused by specific gene mutations that are inherited from parent to child. These specific, inheritable, disease-related gene mutations can be identified through hereditary cancer testing, offering patients a thorough evaluation of their cancer risk. For example, in June 2022, a BioMed Central article on hereditary cancer in clinical practice revealed that roughly 10% of pancreatic cancer cases are genetically linked. Consequently, the escalating incidences of inherited cancer are contributing to the expansion of the hereditary cancer testing market.
Which Sub-Segments Are Driving Growth Within The Hereditary Cancer Testing Market?
The hereditary cancer testingmarket covered in this report is segmented –
1) By Test Type: Multi Panel Test; Single-Site Genetic Test
2) By Indication: Breast Cancer; Ovarian Cancer; Colorectal Cancer; Other Indications
3) By End user: Hospital; Clinics; Diagnostic Centers
Subsegments:
1) By Multi Panel Test: Comprehensive Genetic Panels; Targeted Gene Panels
2) By Single-Site Genetic Test: Specific Gene Testing; Familial Mutation Testing
What Current And Upcoming Trends Are Shaping The Hereditary Cancer Testing Market?
One prominent trend observing significant traction in the hereditary cancer testing market is technological innovation. To maintain their supremacy in the market, notable players are revolving their strategies around tech advancements. Illustratively, in March 2022, US-based genetic testing and precision medicine firm, Myriad Genetics, introduced a genetic test featuring a Polygenic Breast Cancer Risk Assessment Score suitable for all genetic lineages. This MyRisk Hereditary Cancer test combined with RiskScore provides an individualized breast cancer risk evaluation for all women, irrespective of their ancestral roots, who have not previously been diagnosed with the disease.
Which Companies Hold A Competitive Edge In The 131 Market?
Major companies operating in the hereditary cancer testing market are Centogene NV, Ambry Genetics Inc., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Quest Diagnostics, PreventionGenetics, Fulgent Genetics Inc., Invitae Corporation, Medical Diagnostic Laboratories LLC, Natera Inc., Color Health Inc., CooperSurgical Inc., OPKO Health Inc., Illumina Inc., Laboratory Corporation of America Holdings, Pathway Genomics Corporation, Strand Life Sciences Private Limited, Progenity Inc., Myogenes Ltd., Associated Regional and University Pathologists Inc., 4baseCare, Biocartis Group NV, F. Hoffmann-La Roche AG, Medgenome Pvt. Ltd., Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies PLC, PerkinElmer Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/hereditary-cancer-testing-global-market-report
Which Region Dominates The Hereditary Cancer Testing Market Today?
North America was the largest region in the hereditary cancer testing market in 2024. The regions covered in the hereditary cancer testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=8121&type=smp
Browse Through More Reports Similar to the Global Hereditary Cancer Testing Market 2025, By The Business Research Company
Healthcare Analytical Testing Services Global Market Report 2025
Automotive Testing Inspection And Certification Global Market Report 2025
Cold Plasma Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cold-plasma-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
